Executive Order 14256
Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports
This executive order ends duty-free de minimis treatment for low-value imports from China and Hong Kong starting May 2, 2025, imposing either a 30% ad valorem duty or per-item fees ($25 rising to $50) on postal shipments. It requires carriers to collect and remit duties, maintain bonds, and report shipment data to CBP.